Literature DB >> 19665597

Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions.

Matthias Götte1, Jason W Rausch, Bruno Marchand, Stefan Sarafianos, Stuart F J Le Grice.   

Abstract

Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) catalyzes synthesis of integration-competent, double-stranded DNA from the single-stranded viral RNA genome, combining both polymerizing and hydrolytic functions to synthesize approximately 20,000 phosphodiester bonds. Despite a wealth of biochemical studies, the manner whereby the enzyme adopts different orientations to coordinate its DNA polymerase and ribonuclease (RNase) H activities has remained elusive. Likewise, the lower processivity of HIV-1 RT raises the issue of polymerization site targeting, should the enzyme re-engage its nucleic acid substrate several hundred nucleotides from the primer terminus. Although X-ray crystallography has clearly contributed to our understanding of RT-containing nucleoprotein complexes, it provides a static picture, revealing few details regarding motion of the enzyme on the substrate. Recent development of site-specific footprinting and the application of single molecule spectroscopy have allowed us to follow individual steps in the reverse transcription process with significantly greater precision. Progress in these areas and the implications for investigational and established inhibitors that interfere with RT motion on nucleic acid is reviewed here. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665597      PMCID: PMC2930377          DOI: 10.1016/j.bbapap.2009.07.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  97 in total

Review 1.  DNA polymerases: structural diversity and common mechanisms.

Authors:  T A Steitz
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

2.  Temporal coordination between initiation of HIV (+)-strand DNA synthesis and primer removal.

Authors:  M Götte; G Maier; A M Onori; L Cellai; M A Wainberg; H Heumann
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

3.  Localization of the active site of HIV-1 reverse transcriptase-associated RNase H domain on a DNA template using site-specific generated hydroxyl radicals.

Authors:  M Götte; G Maier; H J Gross; H Heumann
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

4.  Refined model for primer/template binding by HIV-1 reverse transcriptase: pre-steady-state kinetic analyses of primer/template binding and nucleotide incorporation events distinguish between different binding modes depending on the nature of the nucleic acid substrate.

Authors:  B M Wöhrl; R Krebs; R S Goody; T Restle
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

5.  Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase.

Authors:  W Tong; C D Lu; S K Sharma; S Matsuura; A G So; W A Scott
Journal:  Biochemistry       Date:  1997-05-13       Impact factor: 3.162

6.  Binding and kinetic properties of HIV-1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription.

Authors:  J M Lanchy; C Ehresmann; S F Le Grice; B Ehresmann; R Marquet
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

7.  Substituting a conserved residue of the ribonuclease H domain alters substrate hydrolysis by retroviral reverse transcriptase.

Authors:  J W Rausch; S F Le Grice
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

8.  Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.

Authors:  H Huang; R Chopra; G L Verdine; S C Harrison
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

9.  Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.

Authors:  J Ding; K Das; Y Hsiou; S G Sarafianos; A D Clark; A Jacobo-Molina; C Tantillo; S H Hughes; E Arnold
Journal:  J Mol Biol       Date:  1998-12-11       Impact factor: 5.469

10.  In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.

Authors:  M Seifer; R K Hamatake; R J Colonno; D N Standring
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.938

View more
  17 in total

1.  The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.

Authors:  Matthew M Schuckmann; Bruno Marchand; Atsuko Hachiya; Eiichi N Kodama; Karen A Kirby; Kamalendra Singh; Stefan G Sarafianos
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

2.  A toolkit and benchmark study for FRET-restrained high-precision structural modeling.

Authors:  Stanislav Kalinin; Thomas Peulen; Simon Sindbert; Paul J Rothwell; Sylvia Berger; Tobias Restle; Roger S Goody; Holger Gohlke; Claus A M Seidel
Journal:  Nat Methods       Date:  2012-11-11       Impact factor: 28.547

3.  Effect of translocation defective reverse transcriptase inhibitors on the activity of N348I, a connection subdomain drug resistant HIV-1 reverse transcriptase mutant.

Authors:  E Michailidis; K Singh; E M Ryan; A Hachiya; Y T Ong; K A Kirby; B Marchand; E N Kodama; H Mitsuya; M A Parniak; S G Sarafianos
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2012-12-22       Impact factor: 1.770

4.  Identification and characterization of a novel HIV-1 nucleotide-competing reverse transcriptase inhibitor series.

Authors:  D Rajotte; S Tremblay; A Pelletier; P Salois; L Bourgon; R Coulombe; S Mason; L Lamorte; C F Sturino; R Bethell
Journal:  Antimicrob Agents Chemother       Date:  2013-04-01       Impact factor: 5.191

Review 5.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

6.  HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors.

Authors:  Paul L Boyer; Patrick K Clark; Stephen H Hughes
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

7.  The mechano-chemistry of a monomeric reverse transcriptase.

Authors:  Omri Malik; Hadeel Khamis; Sergei Rudnizky; Ariel Kaplan
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

Review 8.  Targeting viral reservoirs: ability of antiretroviral therapy to stop viral replication.

Authors:  Frank Maldarelli
Journal:  Curr Opin HIV AIDS       Date:  2011-01       Impact factor: 4.283

9.  A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

Authors:  Sébastien Lyonnais; Robert J Gorelick; Fatima Heniche-Boukhalfa; Serge Bouaziz; Vincent Parissi; Jean-François Mouscadet; Tobias Restle; Jose Maria Gatell; Eric Le Cam; Gilles Mirambeau
Journal:  Virus Res       Date:  2012-09-24       Impact factor: 3.303

Review 10.  Fragment screening and HIV therapeutics.

Authors:  Joseph D Bauman; Disha Patel; Eddy Arnold
Journal:  Top Curr Chem       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.